Skip to content

Research of the algorithm development to detect rare driver gene-positive lung cancer population by histopathological image analysis using artificial intelligence

Research of the algorithm development to detect rare driver gene-positive lung cancer population by histopathological image analysis using artificial intelligence - Research of the algorithm for rare driver gene-positive lung cancer with using histopathological image and artificial intelligence

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000045992
Enrollment
1000
Registered
2021-11-08
Start date
2021-07-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

None listed

Sponsors

National Cancer Center Hospital East / CHUGAI PHARMACEUTICAL CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Non-small cell lung cancer 2. Histopathological image, genetic test results, clinical information, and imaging information 3. Written informed consent in LC-SCRUM-IBIS regarding secondary use of remaining sample and information 4. No rejection against secondary use of remaining sample and information, whose information is provided in the form of opt-out on the web-site

Exclusion criteria

Exclusion criteria: 1. Patients whose participation in the trial is judged to be inappropriate by the doctor

Design outcomes

Primary

MeasureTime frame
The performance of a detection evaluated by the area under the ROC curve, or AUC, for rare driver gene (ALK, ROS1, RET, BRAF, NTRK, MET, HER2, KRAS)

Countries

Japan

Contacts

Public ContactKiyotaka YOH

National Cancer Center Hospital East Department of Thoracic Medical Oncology

kyoh@east.ncc.go.jp04-7133-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026